| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Financial Officer
1 company
Scott Thomas Smith is EVP & Chief Financial Officer at ASND. Scott Thomas Smith's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.1M at current prices.
Net of sales, the ASND filings show accumulation of 350 shares.
Scott Thomas Smith has 2 Form 4 filings on record from May 2026 to June 2026, all as EVP & Chief Financial Officer at Ascendis Pharma A/S (ASND), 2026.
The 2 reported transactions were 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $78K and no sales.
The largest open-market purchase was 250 shares of ASND at an average $223.32 on May 29, 2026, about $56K.